It's hard to imagine that a large pharmaceutical company would not by be interested in the technology owned by Curis. My only concern is whether the company will survive long enough to negotiate a sale. IMO $CRIS
$CRIS Chat GPT how often does EMA approve a drug before FDA? "2022 study published in JAMA Network Open found that from 2011 to 2020, the EMA approved 85 (43%) of 197 new drugs before the FDA." Maybe we hear from EMA before FDA?
$CRIS Part 2: compare recent cancer drug approvals with Curis's Emavusertib: Take Aim trial RR AML 21 patients 10 of 19 evaluable with ORR = 52.6%, 6 CR =31.6%
$CRIS Part 1: ChatGPT what cancer drugs with orphan status were FDA approved in 2024 ? ORR and CR rates: 1, Bizengri 64 eval. ORR 33% CR 1.6%, 2. Tecelra 44 eval. ORR 43.2% CR 4.5%, 3. Vorasidenib PFS of 27.7months vs 11.1 w/Placebo ORR and CR ?, 4. Amtagvi ORR 36% CR3%
https://t.co/I3Gddaw8lw now add patent protection to the mix. With only 8.5M shares outstanding, CRIS stock price has the potential to increase exponentially, IMO $CRIS
How is it that a company with a patented cancer treatment using IRAK 4 is only worth $35 MILLION? Anxiously awaiting EMA or FDA orphan drug approval of Emavusertib $CRIS
Abstract: The present disclosure relates to methods of treating certain diseases and disorders (e.g., cancer) with a combination of an IRAK4 inhibitor, a BCL-2 inhibitor, and a nucleoside analog.
Type: Grant
Filed: February 25, 2022
Date of Patent: December 31, 2024
$CRIS
NOAA has been tracking the formation of Hurricane Milton for days.
They sent hurricane hunters to determine its speed and intensity.
They've identified its path across Florida.
Their data will save hundreds if not thousands of lives.
NOAA is one of the many departments that would be broken up and downsized in a Trump regime.
New clinical trial update to PCNSL study. 8 additional sites now recruiting. Now 37 if I counted correctly. Not sure if the link will post. If not go to https://t.co/IfiK9uSlZz Record History | ver. 19-20: 2024-07-11 | NCT03328078 | https://t.co/K621IoGJVS
60% ORR in this r/r with 3 CR's and one unconfirmed CR. What is the FDA waiting for? There are no available treatments and life expectancy of these patients is about 2 months. Hopefully either the FDA or the EMA (European FDA equivalent) will act soon. $CRIS